NasdaqCM - Nasdaq Real Time Price USD

Streamex Corp. (STEX)

0.3883 -0.0513 (-11.67%)

At close: October 30 at 4:00:00 PM EDT

0.3847 -0.0036 (-0.93%)

After hours: October 30 at 7:01:30 PM EDT

Trade STEX on Coinbase

Chart Range Bar

Advanced Chart

AlphaSpace Chart

Loading chart for STEX

Previous Close 0.4396
Open 0.4290
Bid 0.4200 x 100
Ask 0.3696 x 100
Day's Range 0.3500 - 0.4300
52 Week Range 0.3500 - 5.1200
Volume 1,500,637
Avg. Volume 1,029,434
Market Cap (intraday) 87.575M
Beta (5Y Monthly) 2.02
PE Ratio (TTM) --
EPS (TTM) -9.0400
Earnings Date (est.) Nov 12, 2026
Forward Dividend & Yield -- (0.00%)
1y Target Est 4.00
Motley Fool Rating Bearish

Streamex Corp. engages in developing digital infrastructure for the tokenization and exchange of real-world assets focused on physical gold and gold-linked financial products. Its commodity-backed tokenized product, GLDY, provide investors with exposure to gold through a liquid, yield-bearing structure. The company also offers PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.

www.streamex.com

Full Time Employees

December 31

Fiscal Year Ends

Financial Services

Sector

Capital Markets

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

STEX

87.18%

S&P 500 (^GSPC)

10.73%

1-Year Return

STEX

91.63%

S&P 500 (^GSPC)

11.11%

3-Year Return

STEX

90.53%

S&P 500 (^GSPC)

81.91%

5-Year Return

STEX

98.56%

S&P 500 (^GSPC)

64.59%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 146k

Earnings -14.55M

Profit Margin -9,968.49%

FY25

FY26

-400M

-300M

-200M

-100M

-8000.0%

-6000.0%

-4000.0%

-2000.0%

0.0%

Analyst Price Targets

4.00

4.00 Average

0.3883 Current

4.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Latest Rating

Date 8/18/2026

Analyst Needham

Rating Action Maintains

Rating Buy

Price Action Lowers

Price Target 8 -> 4

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-44.42%
Return on Equity (ttm)

-696.88%
Revenue (ttm)

146k
Net Income Avi to Common (ttm)

-500.84M
Diluted EPS (ttm)

-9.0400

Balance Sheet and Cash Flow

Total Cash (mrq)

20.29M
Total Debt/Equity (mrq)

0.54%
Levered Free Cash Flow (ttm)

-100.82M

GNPX Genprex, Inc.

2.2400 +9.80%

CTXR Citius Pharmaceuticals, Inc.

0.5231 -7.10%

ADIL Adial Pharmaceuticals, Inc.

5.05 +36.12%

HSDT Solana Company

2.0900 -7.52%

CHGA Change Agents Corporation

1.3500 -8.78%

U.S. markets closed

Streamex Corp. (STEX)

Trading disclosure

-11.75%

-39.61%

-49.24%

-87.18%

-91.63%

-98.56%

-99.56%

Streamex Corp. Overview Capital Markets / Financial Services

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch